{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T13:32:01Z","timestamp":1670938321661},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11239-016-1439-z","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T13:18:10Z","timestamp":1478179090000},"page":"263-270","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel mutation in exon 2 of FGB caused by c.221G>T \u2020 substitution, predicting the replacement of the native Arginine at position 74 with a Leucine (p.Arg74Leu \u2020 ) in a proband from a Kurdish family with dysfibrinogenaemia and familial venous and arterial thrombosis"],"prefix":"10.1007","volume":"43","author":[{"given":"Abdul A.","family":"Shlebak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia D.","family":"Katsarou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"1439_CR1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","volume":"3","author":"MW Mosesson","year":"2005","unstructured":"Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3:1894\u20131904","journal-title":"J Thromb Haemost"},{"key":"1439_CR2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","volume":"39","author":"P Moerloose de","year":"2013","unstructured":"de Moerloose P, Casini A, Neerman-Arbez M (2013) Congenital fibrinogen disorders: an update. Semin Thromb Hemost 39: 585\u2013595","journal-title":"Semin Thromb Hemost"},{"key":"1439_CR3","first-page":"855","volume-title":"Hemostasis and thrombosis","author":"J McDonagh","year":"2001","unstructured":"McDonagh J (2001) Dysfibrinogenemia and other disorders of fibrinogen structure or function. In: Colman R, Hirsh J, Marder V, Clowes A, George J, (editors). Hemostasis and thrombosis. 4th\u00a0edn. Lippincott Williams & Wilkins, Philadelphia, pp\u00a0855\u2013892","edition":"4"},{"key":"1439_CR4","volume-title":"Index of variant human fibrinogens","author":"R Ebert","year":"1994","unstructured":"Ebert R (1994) Index of variant human fibrinogens. CRC Press, Boca Raton"},{"key":"1439_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","volume":"73","author":"F Haverkate","year":"1995","unstructured":"Haverkate F, Samama M (1995) Familial dysfibrinogenemia and thrombophilia: report on a study of the SCC Subcommittee on Fibrinogen. Thromb Haemost 73:151\u2013161","journal-title":"Thromb Haemost"},{"key":"1439_CR6","first-page":"39","volume":"58","author":"E Briet","year":"1987","unstructured":"Briet E, Engesser L, Brommer E, Broekmans A, and Bertina R (1987) Thrombophilia: its causes and a rough estimate of its prevalence. Thromb Haemost 58:39 (abstract 146)","journal-title":"Thromb Haemost"},{"key":"1439_CR7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.12085","volume":"160","author":"SE Shapiro","year":"2013","unstructured":"Shapiro SE, Phillips E, Manning RA, Morse CV, Murden SL, Laffan MA, Mumford AD (2013) Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia. Br J Haematol 160:220\u2013227","journal-title":"Br J Haematol"},{"key":"1439_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","volume":"125","author":"A Casini","year":"2015","unstructured":"Casini A, Blondon M, Lebreton A, Koegel J, Tintillier V, de Maistre E, Gautier P, Biron C, Neerman-Arbez M, de Moerloose P (2015) Natural history of patients with congenital dysfibrinogenemia. Blood 125:553\u2013561","journal-title":"Blood"},{"key":"1439_CR9","first-page":"519","volume":"61","author":"P Ness","year":"1983","unstructured":"Ness P, Budzynski A, Olexa S, Rodvien R (1983) Congenital hypofibrinogenemia and recurrent placental abruption. Obstet Gynecol 61:519\u2013523","journal-title":"Obstet Gynecol"},{"key":"1439_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5858\/2002-126-0499-LDOD","volume":"126","author":"MT Cunningham","year":"2002","unstructured":"Cunningham MT, Brandt JT, Laposata M, Olson JD (2002) Laboratory diagnosis of dysfibrinogenemia. Arch Pathol Lab Med 126:499\u2013505","journal-title":"Arch Pathol Lab Med"},{"key":"1439_CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0272-2712(18)30935-1","volume":"4","author":"D Galanakis","year":"1984","unstructured":"Galanakis D (1984) Dysfibrinogenemia: a current perspective. Clin Lab Med 4:395\u2013418","journal-title":"Clin Lab Med"},{"key":"1439_CR12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0889-8588(18)30303-4","volume":"6","author":"D Galanakis","year":"1992","unstructured":"Galanakis D (1992) Fibrinogen anomalies and disease: a clinical update. Hematol Oncol Clin North Am 6:1171\u20131187","journal-title":"Hematol Oncol Clin North Am"},{"key":"1439_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajh.2830380105","volume":"38","author":"H Liebman","year":"1991","unstructured":"Liebman H, Comenzo R, Allen S, Dilorio J (1991) A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer. Am J Hematol 38:24\u201329","journal-title":"Am J Hematol"},{"key":"1439_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V39.2.210.210","volume":"39","author":"M Coleman","year":"1972","unstructured":"Coleman M, Vigliano E, Weksler M, Nachman R (1972) Inhibition of fibrin monomer polymerization by lamda myeloma globulins. Blood 39:210\u2013223","journal-title":"Blood"},{"key":"1439_CR15","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood.V76.11.2249.2249","volume":"76","author":"J Lawson","year":"1990","unstructured":"Lawson J, Pennell J, Olson J et al (1990) Isolation and characterization of an acquired antithrombin antibody. Blood 76:2249\u20132257","journal-title":"Blood"},{"key":"1439_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood.V53.1.81.81","volume":"53","author":"E Marciniak","year":"1979","unstructured":"Marciniak E, Greenwood M (1979) Acquired coagulation inhibitor delaying fibrinopeptide release. Blood 53:81\u201392","journal-title":"Blood"},{"key":"1439_CR17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00001721-199210000-00002","volume":"3","author":"J Gris","year":"1992","unstructured":"Gris J, Schved JF, Branger B, Aguilar-Martinez P, Vecina F, Oul\u00e8s R et al (1992) Autoantibody to plasma fibrinopeptide A in a patient with a severe acquired hemorrhagic syndrome. Blood Coagul Fibrinolysis 3:519\u2013529","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1439_CR18","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V77.12.2637.2637","volume":"77","author":"D Gastineau","year":"1991","unstructured":"Gastineau D, Gertz M, Daniels T, Kyle R, Bowie E (1991) Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality. Blood 77:2637\u20132640","journal-title":"Blood"},{"key":"1439_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0049-3848(83)90004-X","volume":"31","author":"W Fricke","year":"1983","unstructured":"Fricke W, McDonagh J (1983) Thrombin clotting time and fibrinogen concentration in patients treated with coumadin. Thromb Res 31:23\u201328","journal-title":"Thromb Res"},{"key":"1439_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0038-1653779","volume":"73","author":"P Toulon","year":"1995","unstructured":"Toulon P, Frere E, Bachmeyer C, Candia N, Blanche P, Sereni D, Sicard D (1995) Fibrin polymerization defect in HIV-infected patients\u2014evidence for a critical role of albumin in the prolongation of thrombin and reptilase clotting times. Thromb Haemost 73:349\u2013355","journal-title":"Thromb Haemost"},{"key":"1439_CR21","volume-title":"Laboratory evaluation of coagulation","author":"D Triplett","year":"1982","unstructured":"Triplett D and Smith C (1982) Routine testing in the coagulation laboratory. In: Triplett D. Laboratory evaluation of coagulation. ASCP Press, Chicago"},{"key":"1439_CR22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","volume":"167","author":"AD Mumford","year":"2014","unstructured":"Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, Mainwaring J, Mathias M, O\u2019Connell N (2014) BCSH Committee Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 167:304\u2013326","journal-title":"Br J Haematol"},{"key":"1439_CR23","first-page":"760","volume":"36","author":"I Henry","year":"1984","unstructured":"Henry I, Uzan G, Weil D, Nicolas H, Kaplan JC, Marguerie C et al (1984) The gene coding for the A-alpha, B-beta and gamma chains of fibrinogen map to 4q2. Am J Hum Genet 36:760\u2013768","journal-title":"Am J Hum Genet"},{"key":"1439_CR24","doi-asserted-by":"crossref","unstructured":"Hanss M, Biot F (2001) A database for human fibrinogen variants. Ann N.Y. Acad Sci, 936:89\u201390. http:\/\/www.geht.org\/databaseang\/fibrinogen","DOI":"10.1111\/j.1749-6632.2001.tb03495.x"},{"key":"1439_CR25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","volume":"17","author":"A Clauss","year":"1957","unstructured":"Clauss A (1957) Gerinnungsphysiologische schnell-methode zur bestimmung des fibrinogens. Acta Haematol 17:237\u2013246","journal-title":"Acta Haematol"},{"key":"1439_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0038-1648849","volume":"72","author":"S Rosen","year":"1994","unstructured":"Rosen S, Johansson K, Lindberg K, Dahlback B (1994) Multicentre evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. Thromb Haemost 72:255\u2013260","journal-title":"Thromb Haemost"},{"key":"1439_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"R Bertina","year":"1994","unstructured":"Bertina R, Koeleman B, Koster T, Rosendaal F, Dirven R, de Ronde H, van der Velden P, Reitsma P (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64\u201367","journal-title":"Nature"},{"key":"1439_CR28","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"S Poort","year":"1996","unstructured":"Poort S, Rosendaal F, Reitsma P, Bertina R (1996) A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698\u20133703","journal-title":"Blood"},{"key":"1439_CR29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/jcp.44.11.885","volume":"44","author":"Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Taskforce","year":"1991","unstructured":"Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Taskforce (1991) Guidelines on testing for the lupus anticoagulant. J Clin Pathol 44:885\u2013889","journal-title":"J Clin Pathol"},{"key":"1439_CR30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jcp.46.2.104","volume":"46","author":"M Khamashta","year":"1993","unstructured":"Khamashta M, Hughes G (1993) ACP broadsheet no. 136: February 1993. Detection and importance of anticardiolipin antibodies. J Clin Pathol 46:104\u2013107","journal-title":"J Clin Pathol"},{"issue":"2","key":"1439_CR31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin M, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306","journal-title":"J Thromb Haemost"},{"key":"1439_CR32","unstructured":"Wallis Y, Payne S, McAnulty C, Bodmer D, Sister-mans E, Robertson K et al (2013) Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. Assoc Clin Genet Sci Dutch Soc Clin Genet Lab Spec. http:\/\/www.ngrl.org.uk\/publications\/Informatics\/NGRL_Splice_Site_Tools_Analysis_2009"},{"key":"1439_CR33","doi-asserted-by":"crossref","first-page":"10421","DOI":"10.1016\/S0021-9258(19)86724-8","volume":"254","author":"C Liu","year":"1979","unstructured":"Liu C, Nossel H, Kaplan K (1979) The binding of thrombin by fibrin. J Biol Chem 254:10421\u201310425","journal-title":"J Biol Chem"},{"key":"1439_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0038-1661463","volume":"55","author":"F Haverkate","year":"1986","unstructured":"Haverkate F, Koopman J, Kluft C, d\u2019Angelo A, Cattaneo A, Mannucci P (1986) Fibrinogen Milano II: a congenital dysfibrinogenemia associated with juvenile arterial and venous thrombosis. Thromb Haemost 55:131\u2013135","journal-title":"Thromb Haemost"},{"key":"1439_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/9783110871951-011","volume-title":"Fibrinogen, Fibrin Formation and Fibrinolysis","author":"C Liu","year":"1986","unstructured":"Liu C, Wallen P, and Handley D (1986) Fibrinogen New York I: the structural, functional and genetic defects and hypothesis of the role of fibrin in the regulation of coagulation and fibrinolysis. In: Lane D, Henschen A, Jasani M (editors). Fibrinogen, Fibrin Formation and Fibrinolysis. Walter de Gruyter, New York 4:79"},{"key":"1439_CR36","first-page":"25","volume-title":"Fibrinogen and its derivatives. Biochemistry, Physiology and Pathophysiology","author":"J Fernandez","year":"1986","unstructured":"Fernandez J, Paramo J, Cuesta B, Aranda A, and Rocha E (1986) Fibrinogen Pamplona II: a new congenital dysfibrinogenemia with abnormal fibrin-enhanced plasminogen activation and defective binding of thrombin to fibrin. In: Muller-Berghaus G, Scheefers-Borchel U, Selmayr E, Henschen A, (editors). Fibrinogen and its derivatives. Biochemistry, Physiology and Pathophysiology. Elsevier, New York, pp\u00a025\u201330"},{"key":"1439_CR37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2141.1983.tb07309.x","volume":"53","author":"J Soria","year":"1983","unstructured":"Soria J, Soria C, Caen P (1983) A new type of congenital dysfibrinogenaemia with defective fibrin lysis\u2014Dusard syndrome: possible relation to thrombosis. Br J Haematol 53:575\u2013586","journal-title":"Br J Haematol"},{"key":"1439_CR38","first-page":"515","volume-title":"Haemostasis and Thrombosis","author":"J Koopman","year":"1994","unstructured":"Koopman J, Haverkate F (1994) Hereditary variants of human fibrinogens. In: Bloom F, Forbes CD, Thomas DP, Tuddenham EGD (eds) Haemostasis and Thrombosis, vol\u00a01. Churchill Livingstone, Edinburgh, p\u00a0515"},{"key":"1439_CR39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(93)90063-V","volume":"72","author":"J Miletich","year":"1993","unstructured":"Miletich J, Prescott S, White R, Majerus P, Bovill E (1993) Inherited predisposition to thrombosis. Cell 72:477\u2013480","journal-title":"Cell"},{"key":"1439_CR40","first-page":"382","volume":"1560","author":"M Mosesson","year":"1997","unstructured":"Mosesson M, Siebenlist K, Olson J (1997) Thrombophilia associated with dysfibrinogenemia [fibrinogen Cedar Rapids (\u03b3R275C)] and a heterozygous factor V Leiden defect. Thromb Haemost 1560:382 (abstr, suppl)","journal-title":"Thromb Haemost"},{"key":"1439_CR41","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V92.7.2195","volume":"92","author":"H Cote","year":"1998","unstructured":"Cote H, Lord S, Pratt K (1998) \u03b3-Chain dysfibrinogenemias: molecular structure\u2013function relationships of naturally occurring mutations in the \u03b3-chain of human fibrinogen. Blood 92:2195\u20132212","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1439-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1439-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1439-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T05:20:03Z","timestamp":1657603203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1439-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1439-z","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}